The grey market premium (GMP) for Akums Drugs IPO shares rose by nearly 7 per cent ahead of the listing on the BSE and NSE, indicating moderate listing gains for investors
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
The grey market premium (GMP) for Akums Drugs IPO shares rose by nearly 7 per cent ahead of the listing on the BSE and NSE, indicating moderate listing gains for investors
| Subscribe To Our Free Newsletter |
